Metropolis Healthcare shares hit 52-week high post Q4 results; should you buy or wait?

Metropolis Healthcare share price target, Metropolis Healthcare share price today NSE, Metropolis Healthcare Q4 results: Metropolis Healthcare shares on Wednesday, May 22 gained as much as 7.7 per cent to clock a 52-week high of Rs 2,050 on NSE. The positive trend followed after the diagnostics company reported a set of quarterly earnings that largely met analysts' expectations. The stock closed 3.12 per cent higher at Rs 1,962.1 on NSE.

Metropolis Healthcare Q4 results

Metropolis Healthcare reported an 8 percent year-on-year rise in consolidated net profit at Rs 36 crore for the March quarter. Metropolis's revenue came in at Rs 313 crore, up 11 percent from the year-ago quarter's Rs 282 crore.

Zee Business analysts had pegged the diagnostics company's quarterly net profit at Rs 39 crore and revenue at Rs 312 crore. 

Metropolis Healthcare share price target: Buy, sell or hold?

Morgan Stanley has maintained an equalweight rating on Metropolis Healthcare with a target of Rs 1,792. The brokerage highlighted the following key points in its note: 

• Q4 reported EBITDA grew 15%, in line with estimates
• Q4 core revenues were up 15% YoY, led by 7.3% core patient volumes growth
• Contribution was stable QoQ at 15% of total revenues

For all other news related to business, politics, tech and auto, visit Zeebiz.com.